| 000 | 01694 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517100224.0 | ||
| 264 | 0 | _c20170425 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1720-8386 | ||
| 024 | 7 |
_a10.1007/s40618-016-0483-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSala, E | |
| 245 | 0 | 0 |
_aRecurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas. _h[electronic resource] |
| 260 |
_bJournal of endocrinological investigation _cDec 2016 |
||
| 300 |
_a1377-1382 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCabergoline |
| 650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
| 650 | 0 | 4 |
_aErgolines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperprolactinemia _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 |
_aPituitary Neoplasms _xcomplications |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProlactinoma _xcomplications |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 650 | 0 | 4 | _aWithholding Treatment |
| 700 | 1 | _aBellaviti Buttoni, P | |
| 700 | 1 | _aMalchiodi, E | |
| 700 | 1 | _aVerrua, E | |
| 700 | 1 | _aCarosi, G | |
| 700 | 1 | _aProfka, E | |
| 700 | 1 | _aRodari, G | |
| 700 | 1 | _aFilopanti, M | |
| 700 | 1 | _aFerrante, E | |
| 700 | 1 | _aSpada, A | |
| 700 | 1 | _aMantovani, G | |
| 773 | 0 |
_tJournal of endocrinological investigation _gvol. 39 _gno. 12 _gp. 1377-1382 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40618-016-0483-z _zAvailable from publisher's website |
| 999 |
_c26077036 _d26077036 |
||